Advertisement

Multimedia

» antibiotic resistance and cancer

Video, Slideshows, Infographics

Most Recent

image: <em>The Scientist</em> on the Pulse, April 23

The Scientist on the Pulse, April 23

By | April 23, 2015

Hot topics in cancer research from the annual meeting of the American Association for Cancer Research

0 Comments

image: Cancer Immunotherapist

Cancer Immunotherapist

By | April 1, 2015

Scientist to Watch Yvonne Saenger explains recent advances in using biomarkers to identify cancer patients who might benefit most from immunotherapy.

0 Comments

image: Tracking Miracles

Tracking Miracles

By | April 1, 2015

A panel of oncologists discusses cases of exceptional responders, or cancer patients whose tumors disappear after a brief period of chemotherapy.

0 Comments

image: Poor Little Devils

Poor Little Devils

By | November 1, 2014

See the devastating infectious cancer that may drive the Tasmanian Devil to extinction.

0 Comments

image: Targeting Tumors with Viruses

Targeting Tumors with Viruses

By | June 1, 2014

Stephanie Swift discusses the strategy of fighting cancer with viruses.

0 Comments

image: Superbugs Ascending

Superbugs Ascending

By | April 1, 2014

University of Texas at San Antonio microbiologist Karl Klose discusses the problem of antibiotic resistance in a 2013 TEDx talk.

0 Comments

image: Cancer Whisperer

Cancer Whisperer

By | July 1, 2013

Profile subject Cédric Blanpain describes his work rooting out the role of stem cells in tumors.

0 Comments

image: Blue Biotech

Blue Biotech

By | March 1, 2013

Systems biologist Lone Gram describes her approach to combing the oceans for novel compounds that may be useful in the fight against pathogens.

0 Comments

image: Telomere Basics

Telomere Basics

By | May 1, 2012

Telomeres are repetitive, noncoding sequences that cap the ends of linear chromosomes. They consist of hexameric nucleotide sequences (TTAGGG in humans) repeated hundreds to thousands of times. 

4 Comments

image: Designing Transition-State Inhibitors

Designing Transition-State Inhibitors

By | May 1, 2012

A transition-state mimic has the power to bind an enzyme at its tipping point as strongly as any available inhibitor and more strongly than most, preventing enzymatic activity. 

0 Comments

Advertisement

Popular Now

  1. Most Earth-like Planet Found
  2. AAAAA Is for Arrested Translation
  3. Four-legged Snake Fossil Found
  4. The Sum of Our Parts
    Features The Sum of Our Parts

    Putting the microbiome front and center in health care, in preventive strategies, and in health-risk assessments could stem the epidemic of noncommunicable diseases.

Advertisement
Advertisement